Article
Adaptive landscape of the metallo-β-lactamase NDM to emerging β-lactam-based therapies
2026-07-13
Abstract excerpt
The New Delhi metallo-β-lactamase (NDM) is a major determinant of carbapenem resistance. This has prompted the development of novel therapeutic strategies to treat NDM producers. Since these therapies impose new selective pressures, their clinical deployment may favor NDM variants carrying escape mutations. To anticipate these events and inform future therapeutic decisions, we explored the evolutionary landscape o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d0efa2f-95cc-5c28-b0b3-95e61b918457
- DOI
- 10.64898/2026.07.10.737697
